Weekly Recap | Gilead Sciences -4.82%, most brokers rate it buyWeekly Review·Sep 12 at 08:16 AMGILD-0.52%
Weekly Recap | Vertex Pharma -5.62%, low-volume pullback lags the S&P 500Weekly Review·Sep 12 at 07:06 AMVRTX-1.72%
Weekly Recap | Illumina -5.39%, insider selling fuels valuation debateWeekly Review·Sep 12 at 06:07 AMILMN-1.18%
Weekly Recap | Gilead Sciences +3.65%, FDA approves new HIV tabletWeekly Review·Sep 5 at 07:02 AMGILD-0.52%
Weekly Recap | Gilead Sciences -0.3%, FDA approves once-daily HIV pillWeekly Review·Aug 29 at 05:38 AMGILD-0.52%
